2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

Zamorano, JL; Lancellotti, P; Rodriguez Muñoz, D; Aboyans, V; Asteggiano, R; Galderisi, M; Habib, G; Lenihan, DJ; Lip, GY; Lyon, AR; Lopez Fernandez, T; Mohty, D; Piepoli, MF; Tamargo, J; Torbicki, A; Suter, TM

doi:https://www.dx.doi.org/10.1093/eurheartj/ehw211

File(s)

ESC Cardio-Oncology Position Statement EHJ 2016.pdf (1.17 MB)

Published version

Author(s)

Zamorano, JL

Lancellotti, P

Rodriguez Muñoz, D

Aboyans, V

Asteggiano, R

more

Type

Journal Article

Date Issued

2016-08-26

Date Acceptance

2016-08-01

Citation

European Heart Journal, 2016, 37 (36), pp.2768-2801

URI

http://hdl.handle.net/10044/1/40176

DOI

https://www.dx.doi.org/10.1093/eurheartj/ehw211

ISSN

1522-9645

Publisher

Oxford University Press

Start Page

2768

End Page

2801

Journal / Book Title

European Heart Journal

Volume

37

Issue

36

Copyright Statement

Subjects

European Society of Cardiology

arrhythmias

cancer therapy

cardio-oncology

cardiotoxicity

chemotherapy

early detection

ischaemia

myocardial dysfunction

surveillance

Authors/Task Force Members

ESC Committee for Practice Guidelines (CPG):

Cardiovascular System & Hematology

1102 Cardiovascular Medicine And Haematology

Publication Status

Published